SCHEMBL5149394

SCHEMBL5149394

CCOC(=O)CCn1c2ccccc2c2ccc(O)cc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.58
FNTA P49354 1/20 0.56
FNTB P49356 1/20 0.56
PSEN1 P49768 2/20 0.55
PSEN2 P49810 2/20 0.55
APH1B Q8WW43 2/20 0.55
NCSTN Q92542 2/20 0.55
APH1A Q96BI3 2/20 0.55
PSENEN Q9NZ42 2/20 0.55
KDM4E B2RXH2 3/20 0.53
CREBBP Q92793 1/20 0.51
RAB9A P51151 1/20 0.50
TNF P01375 1/20 0.49
FABP3 P05413 1/20 0.49
FABP4 P15090 1/20 0.49
FABP5 Q01469 1/20 0.49
TDP1 Q9NUW8 1/20 0.46
CTNNB1 P35222 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1128275 0.89 FNTA (0.68) CNR2FNTAFNTBPSEN1PSEN2
SCHEMBL5151427 0.84 PSEN1 (0.60) CNR2FNTAFNTBPSEN1PSEN2
SCHEMBL5156641 0.83 PSEN1 (0.61) CNR2FNTAFNTBPSEN1PSEN2
SCHEMBL12938925 0.80 TNF (0.64) CNR2FNTAFNTBPSEN1PSEN2
SCHEMBL5149406 0.79 PSEN1 (0.57) CNR2FNTAFNTBPSEN1PSEN2
SCHEMBL10756544 0.79 ALDH1A1 (0.56) CNR2PSEN1PSEN2APH1BNCSTN
SCHEMBL5151272 0.79 PSEN1 (0.62) CNR2FNTAFNTBPSEN1PSEN2
SCHEMBL1004476 0.79 TNF (0.63) CNR2FNTAFNTBPSEN1PSEN2
SCHEMBL1004093 0.79 TNF (0.63) CNR2FNTAFNTBPSEN1PSEN2
SCHEMBL5151356 0.78 PSEN1 (0.61) CNR2FNTAFNTBPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor PTGER2, PTGER1, PTGDR2 CNR2 5/4885FNTA 890/4885FNTB 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.